Ultra-Rare BRD9 Loss-of-Function Variants Limit the Antiviral Action of Interferon
Nina K. Mair(University of Zurich), Benjamin G. Hale(University of Zurich)
Cited by 6
Related Papers
An influenza virus-triggered SUMO switch orchestrates co-opted endogenous retroviruses to stimulate host antiviral immunity
|Proceedings of the National Academy of Sciences|2019|113
Proximal protein landscapes of the type I interferon signaling cascade reveal negative regulation by PJA2
|Nature Communications|2024|13
An atlas of protein phosphorylation dynamics during interferon signaling
|Proceedings of the National Academy of Sciences|2025|7
TRIM28 is a target for paramyxovirus V proteins
|PLoS Pathogens|2025|1
Genome-Wide CRISPR Screening Identifies BRD9 as a Druggable Component of Interferon-Stimulated Gene Expression and Antiviral Activity
|bioRxiv (Cold Spring Harbor Laboratory)|2021|0